We have raised the profile of:

Arc4Health

Wavelength introduced Arc4Health, an innovative medical device that delivers microcurrent therapy, transforming the lives of people living with chronic pain. Within a year, we achieved audience reach of five million, including international markets. www.arcmicrotech.com/arc4health

EarFold

Wavelength introduced EarFold to the market. Extensive media coverage of this device that corrects prominent ears without surgery led to a six-month waiting list after just one press release. Our coverage ultimately influenced Allergan’s acquisition of the EarFold device.

LINX® Reflux Management System

Wavelength introduced the LINX® Management System for chronic reflux, gaining attention from health journalists using strong clinical studies and research. Extensive exposure led to Johnson & Johnson’s acquisition of the LINX® Reflux Management System. www.jnjmedtech.com/en-GB/treatment/LINX-reflux-surgery

GC Aesthetics

Wavelength worked with GC Aesthetics, the parent brand of UK breast implants (Nagor) and French range Eurosilicone, managing PR, social media, and liaising with markets and distributors. Wavelength handled international social media strategies and global crisis management. www.gcaesthetics.com